Dermatology Times profiles new Castle Biosciences Melanoma test

Gene expression profiling with a commercially available test (DecisionDx-Melanoma, Castle Biosciences) provides useful prognostic information for patients with high-risk cutaneous melanoma who undergo sentinel lymph node (SLN) biopsy, and particularly for those found to be node-negative, according to a study presented at the annual meeting of the American Society for Clinical Oncology.

Read More →

Castle BiosciencesCharles CornaireOctober 20, 20142014

HealthQuest Announces Fund Closing

HealthQuest Capital is happy to announce the final closing of our inaugural Fund I, at $110M. Originally targeted at $50M, with a focus on medical devices, diagnostics, healthcare IT and consumer medicine.

Read More →

HealthQuestCharles CornaireAugust 29, 20142014

CNO Leads $1M charge for new uniforms (Vestagen)

The CNO of a Florida health system calls the organization's switch to new uniforms for 6,000 employees 'change management at its finest.

Read More →

VestagenCharles CornaireAugust 26, 20142014

Castle Biosciences Announces $11.8M Financing

Castle Biosciences, Inc., a cancer-focused molecular diagnostics company, today announced the completion of an $11.8 million financing. The round was led by new investor HealthQuest Capital, with participation by Castle Biosciences’ current investors including Mountain Group Capital and Affiliates, Longfellow Venture Partners and others. In conjunction with this financing, Garheng Kong, M.D., Ph.D., Managing Partner of HealthQuest Capital, will join Castle Biosciences’ Board of Directors.

Read More →

Castle BiosciencesCharles CornaireAugust 13, 20142014

HealthQuest leads $11.8M financing at Castle Biosciences

Houston-based Castle Biosciences Inc., a molecular diagnostics company with a focus on treating cancer, has just revealed its resolution of financing worth $11.8 million. This round of funding was primarily the result of the company’s latest investor, HealthQuest Capital.

Read More →

HealthQuestCharles CornaireAugust 8, 20142014

Baptist Hospital Jacksonville Converts Staff to Vestex

A local health care company is using new technology to fight viruses, bacteria and infection. It's outfitting workers and patients with a material that literally repels disease. The spread of infection to patients is one of the biggest threats at local hospitals.

Read More →

VestagenCharles CornaireJune 24, 20142014

Vestagen Signs Licensing and Distribution Agreements with Medical Superstore Allheart.com

Vestagen Technical Textiles, Inc., today announced that it has entered into agreements with Scrubs AC, Inc., d/b/a allheart, to produce and distribute protective garments for the healthcare sector manufactured using Vestagen's Vestex protective frabric.

Read More →

VestagenCharles CornaireMay 7, 20142014

FAST Launches Upset Stomach Relief

First Aid Shot Therapy, makers of First Aid Shot Therapy Pain Relief, today announced the launch of its newest offering, First Aid Shot Therapy Upset Stomach. Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. It comes in a great-tasting, smooth, ready-to-drink, liquid shot form, which starts to work immediately.

Read More →

First Aid Shot TherapyCharles CornaireApril 2, 20142014

First Aid Shot Therapy Introduces Upset Stomach Relief

First Aid Shot Therapy, makers of First Aid Shot Therapy Pain Relief, today announced the launch of its newest offering, First Aid Shot Therapy Upset Stomach. Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. It comes in a great-tasting, smooth, ready-to-drink, liquid shot form, which starts to work immediately.

Read More →

First Aid Shot TherapyCharles CornaireApril 2, 20142014

F.A.S.T. Money: ZICO’s Rampolla Invests in New Shot Brand

First Aid Shot Therapy (F.A.S.T.), a brand of condition-specific shots that are designed to offer liquid versions of over-the-counter remedies, is launching in Boston behind a second round of funding, one that included a very familiar name in these parts.

Read More →

First Aid Shot TherapyCharles CornaireFebruary 26, 20142014

HealthQuest participates in financing for F.A.S.T.

First Aid Shot Therapy® (F.A.S.T.), a consumer healthcare company focused on over-the-counter (OTC) medicine in liquid ‘shot’ form, announced today that it has completed a Series B financing round.

First Aid Shot Therapy, HealthQuestCharles CornaireFebruary 10, 20142014

Vestagen Obtains Worldwide Rights to Schoeller Technologies Underlying Key Properties of its Vestex® Protective Healthcare Uniforms

Vestagen Technical Textiles, Inc., today announced that it has obtained worldwide rights from Schoeller Technologies AG to certain technologies that are integral to the unique properties of Vestex, the first of its families of active barrier protective fabrics that are clinically proven to prevent or reduce the acquisition and retention of microbes and other contaminants.

Read More →

VestagenCharles CornaireFebruary 4, 20142014